|
The Office of the Vice President for Research (OVPR) developed this weekly e-newsletter to share important news, resources and funding opportunities related to COVID-19.
|
|
COVID-19 research town hall video
U-M research leadership hosted a virtual town hall on April 14 to answer questions and provide guidance on research operations amid the COVID-19 pandemic.
Access the video
|
|
NIH resource analyzes COVID-19 literature
Building on the collaborative COVID-19 Research Dataset (CORD-19) effort, NIH has collected a comprehensive listing of COVID-19 publications and preprints that is freely available to the public; it features a user-friendly portfolio analysis interface for full text and data queries. The portfolio is designed for flexibility and ease-of-use for researchers, and will be updated daily with new literature selected for inclusion by subject matter experts.
Access the NIH COVID-19 Portfolio
Find out more about how to pursue NIH Urgent and Emergency competing revisions and administrative supplements to fund COVID-19 research.
|
|
COVID-19 Biorepository
To coordinate COVID-19 patient sample collection, distribution and tracking, the Medical School's Clinical Trials Support Office is working with the Central Biorepository to centralize the collection of COVID-19 residual clinical samples and research blood draws and blood processing.
Principal investigators interested in obtaining access to these samples must submit proposals to the UMOR COVID-19 Research Prioritization Committee and receive IRB approval. For researchers interested in accessing samples:
- Submit a UMOR COVID-19 Research Prioritization form
- Submit an IRB application
- After UMOR priority designation, interested PIs will receive a form to provide details regarding sample needs and contact information
- After IRB approval, investigators can reach out for sample* pick-up consistent with their IRB approval
*Samples are dependent on availability.
|
|
Internal funding to support COVID-19 research
|
|
COVID-19 Research Index
U-M researchers across a variety of disciplines are using their expertise to address the global COVID-19 pandemic.
In an effort to increase awareness and foster collaboration among U-M researchers studying the novel coronavirus, OVPR created a COVID-19 Research Index that lists more than 150 projects in all stages of development — from planning to fully launched.
Access the research index
Index your COVID-19 research
|
|
Tracking COVID-19 research
Dimensions, the scholarly search database behind Michigan Research Experts, has collated a publicly available spreadsheet that tracks global COVID-19-related publications, clinical trials, datasets and grants. Those with questions may reach out to support@dimensions.ai.
Access the Dimensions resource
|
|
National COVID-19 HPC Consortium
The COVID-19 High Performance Computing (HPC) Consortium is a unique private-public effort spearheaded by the White House Office of Science and Technology Policy, the U.S. Department of Energy and IBM to bring together federal government, industry and academic leaders who are volunteering free compute time and resources on their world-class machines.
Submit a request to access consortium resources
|
|
Blood donations needed
There is a critical need for blood donations during the pandemic. The U-M Athletic Department and Department of Anesthesiology are co-sponsoring a blood drive on Wednesday, May 6, 7 a.m. to 7 p.m., at the Junge Family Champions Center, 333 E. Stadium Blvd.
Schedule an appointment
|
|
RD support to help mobilize research teams
UMOR's Research Development team offers funding consultations and proposal development services for pulling together external applications, as well as virtual facilitation services for ideation sessions or project planning. The team can help you brainstorm with old and new collaborators, hone research questions, generate specific aims and develop plans for propelling the project forward.
Contact Jill Jividen, Director of Research Development, for more information (jjgoff@umich.edu, or 803-429-6320).
|
|
Newest External Funding Opportunities
|
|
|
|
|
|
